Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Q2 Revenue Grew, Though Robotic Sales Shriveled

This update serves to correct that Beckman Coulter reported net earnings, not net losses, during the second quarter.


NEW YORK  July 31 - Beckman Coulter today posted a modest uptick in second-quarter revenue atop increased R&D spending and increased earnings. However, sale of lab-automation and genetic-analysis tools shrank.


Total revenue for the period ended June 30 increased to $551.8 million from $516.1 million one year ago. Receipts from lab-automation and genetic analysis instruments in the quarter fell more than 10 percent to $39.2 million year over year, while centrifuge and analytical-system sales increased by 1.9 percent to $69.7 million, Beckman said.


Second-quarter R&D spending increased to $48 million from $47.8 million during the same period one year ago. As a result, net income in the quarter grew to $52.2 million, or $.86 per share, from $41.9 million, or $.68 per share, for the same quarter 2002.


Beckman CEO John Wareham said In the third quarter, we expect sales to be up 7 percent to 8 percent. Sales of biomedical research products, which contains Beckman's lab-automation and genetic- and protein-analysis tools, should grow in the low single digits, he said.

"In biomedical research we are cautiously optimistic about R&D spending in the government funded and pharmaceutical sectors, but still bearish on biotechnology R&D spending," Wareham said in a statement.


He added that forthcoming new-product releases, like the ProteomeLab PF 2D, the ProteomeLab PA 800 protein-characterization system, and the CEQ 8800 genetic-analysis system, should aid sales growth in the second half.

Beckman said it had around $66.6 million in cash and cash equivalents as of June 30.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.